Komori
Adjuvant Holdings (4929) · InitiativeAdvanced

Hair Aging Care Through Joint Research with RIKEN and Other Institutions

First written in FY2016. 10 of 14 entries say "Advanced", first in FY2017. Latest entry: 2026-10-21.

14entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2019 – FY2022-Q1AdvancedFY2022-Q3 – 2026-10-212016: 120162017: 120172018: 120182019: 120192020: 120202021: 420212022: 220222023: 120232024: 020242025: 020252026: 22026
Same theme, other companies
Hair Aging Care Through Joint Research with RIKEN and Other InstitutionsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-10-21AdvancedOther Disclosures

    「当社は今後も北海道大学との共同研究を通じて、細胞レベルから肌や毛髪の機能にアプローチする化粧品技術の創出に取り組んでまいります。」

    北海道大学との共同研究について、ミトコンドリアへ美容成分を届ける粒子の大量調製、細胞内でのミトコンドリア近傍への集積確認、機能性原料を内包した粒子による作用評価まで進展している。将来的な皮膚・毛髪向けエイジングケア製品への応用も示している。
  2. FY2026AdvancedAnnual report

    「Through joint research with Hokkaido University, Ajuban Cosme Japan Co., Ltd. identified a new useful raw material that promotes the repair of mitochondrial DNA damage associated with aging and presented the findings at the 145th Annual Meeting of the Pharmaceutical Society of Japan in Fukuoka, held from 27 to 29 March 2025 at the Fukuoka International Congress Center. The findings may lead to the control of skin aging at the cellular level, and the Company will proceed with developing aging-care cosmetics and scalp-care products containing the raw material.」

    The Company's joint research with an external research institution progressed to the stage of identifying a new useful raw material through research with Hokkaido University, presenting the findings at an academic conference, and developing aging-care and scalp-care products.
  3. FY2023AdvancedAnnual report

    「At the 27th Annual Meeting of the Japanese Society of Clinical Hair Research held in November 2022, under the title “The Potential of New Hair-Growth Ingredients from the Perspective of Regenerative Medicine Researchers,” Takashi Tsuji of the Organogenesis Research Team at RIKEN's Center for Biosystems Dynamics Research reported evidence on a new hair-growth ingredient discovered through joint research, while Akio Sato of Tokyo Memorial Clinic reported the results of a clinical study of a hair-growth product containing the new ingredient.」

    The joint research with RIKEN progressed to the stage of reporting at an academic conference in November 2022 both evidence on a new hair-growth ingredient discovered through the research and clinical study results for a hair-growth product containing it.
  4. FY2022AdvancedAnnual report

    「The Company presented research findings on sphingolipids, one of several hair-growth-promoting ingredients discovered by the joint research team of the Group and RIKEN, at the 296th Tokai Regional Meeting of the Japanese Dermatological Association held in June 2021. In addition, after six years of joint research, it began selling the NUOSS men's hair-growth-care series, developed by focusing exclusively on what is necessary to establish a foundation for men's hair-growth care through an in-depth understanding of men's hair and life cycles, via its brand website and other channels on 5 October 2021.」

    The Company progressed from presenting its research findings with RIKEN at an academic conference to launching men's hair-growth-care products after six years of development.
  5. FY2022-Q3AdvancedAnnual report

    「Hair-care product sales continued to perform well and exceeded the previous fiscal year's level, even though one year had passed since the launch of KASUI, introduced in the previous fiscal year. As a result, sales for the cumulative first three quarters of the current fiscal year were ¥2,326 million, up 10.5% year on year.」

    KASUI, the Company's proprietary-formulation product based on the results of joint research with RIKEN, continued to perform well more than one year after launch, and hair-care sales increased 10.5% year on year.
  6. FY2022-Q2RestatedAnnual report

    「Hair-care product sales exceeded the previous fiscal year's level, partly because KASUI, launched in the previous fiscal year, continued to perform well.」

    KASUI, the Company's proprietary-formulation product based on functional ingredients identified through joint research with RIKEN, continued to record strong sales after its launch.
  7. FY2022-Q1AdvancedAnnual report

    「Hair-care product sales exceeded the previous fiscal year's level, partly because KASUI, launched in the previous fiscal year, performed well. As a result, sales for the first quarter of the current fiscal year were ¥742 million, up 26.5% year on year. KASUI KASUI is a new hair-care brand for which the Company identified functional ingredients through joint research with RIKEN and subsequently developed its own formulation.」

    KASUI, the Company's proprietary-formulation product based on the results of joint research with RIKEN, recorded strong sales after launch, and hair-care sales increased 26.5% year on year.
  8. FY2021AdvancedAnnual report

    「The Company announced at an academic conference hosted by JSCHR (the Japanese Society of Clinical Hair Research) in November 2020 that the functional peptide discovered by the joint research team of the Company and RIKEN has hair-growth-promoting effects. It has also filed a patent application.」

    In November 2020, the Company presented at an academic conference the hair-growth-promoting effects of a functional peptide identified through joint research with RIKEN and filed a patent application.
  9. FY2021-Q3AdvancedAnnual report

    「In October last year, we launched KASUI as a new haircare brand and Jalire as a system treatment.」

    For KASUI, which was developed using functional hair ingredients identified through joint research with RIKEN, the Company proceeded with the launch. Commercialization of the results of the joint research has advanced to the next stage.
  10. FY2021-Q2AdvancedAnnual report

    「Through joint basic research with RIKEN, the Company identified functional ingredients related to hair and the scalp. It then developed the proprietary-formulation new hair-care brand KASUI and the system treatment Jalire, which uses internal hair repair to bring hair closer to a more manageable condition, and was conducting promotional activities ahead of their launch on 1 October.」

    The Company is applying functional ingredients related to hair and the scalp obtained through joint basic research with RIKEN to the commercialization of proprietary-formulation products and preparations for their launch.
  11. FY2019AchievedAnnual report

    「The Company had been promoting joint research, but it ended the research at the end of March of that year after achieving certain results. Going forward, it will apply the results obtained through the joint research to aging care for hair and the scalp, as well as to the development of new functional cosmetics for life and health care to support fulfilling lives in a super-aged society.」

    The joint research with RIKEN and other institutions ended at the end of March 2019 after achieving certain results, and the Company has moved to the stage of applying those results to aging care for hair and the scalp and to the development of functional cosmetics.
  12. FY2018RestatedAnnual report

    「Going forward, the Company will apply the results obtained through this joint research to aging care for hair and the scalp, as well as to the development of new functional cosmetics for life and health care to support fulfilling lives in a super-aged society.」

    It reaffirms the policy of applying the results of joint research with RIKEN and other institutions to aging care for hair and the scalp and to functional cosmetics.
  13. FY2017AdvancedAnnual report

    「The Company's main current activity is screening for the targeted ingredients by applying RIKEN's expertise and narrowing the selection to ingredients that demonstrate efficacy.」

    It states that the joint research has progressed to the stage of narrowing down ingredients that demonstrate efficacy.
  14. FY2016First statedAnnual report

    「The Company will apply the results of this joint research to aging-care products for hair and the scalp, as well as to the development of new functional cosmetics for life and health care to support fulfilling lives in an aging society.」

    It outlines a plan to apply the results of joint research with external research institutions to the development of functional cosmetics.
Moved together

"Expansion in the Number of ADJUVANT Salons in Japan" moved the same way as this thread, in the same document, in 9 of its 14 moves.

975433★123456
  1. ★This thread
  2. 1Expansion in the Number of ADJUVANT Salons in Japan9×
  3. 2Accelerating the development of in-house-formulated, high-performance products through the establishment of a new research institute7×
  4. 3Expanding the Product Lineup Toward Total Beauty Solutions5×
  5. 4Improving Revenue and Operating Profit Margin4×
  6. 5Stable sales growth through expansion of core series3×
  7. 6Strengthening Consultative Sales Using the MAP System3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Adjuvant Holdings's next results are scheduled for 2026-10-21. Read the earnings preview It last moved in the Other Disclosures of 2026-10-21: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.